Radiomedix Announces A $40 Million Series A Financing For The Advancement Of Novel Targeted Alpha Therapy Platform And Diagnostic Companion Radiopharmaceuticals To Address Unmet Needs In Oncology; Michael Lee-Chin Appointed To The Board Of The Company
Amount Raised
$40 Million
Round Type
Series A
HoustonBiotechnologyHealth CareTherapeuticsDescription
RadioMedix, Inc. (“RadioMedix” or “Company”), a clinical-stage biotechnology company announced an agreement with an entity related to Portland Investment Counsel Inc. (“Portland”) involving an equity investment of $40 million Series A funding round. RadioMedix is committed to the advancement of a targeted alpha therapy (TAT) pipeline and diagnostic companion radiopharmaceuticals for rare and aggressive cancers.
Quick answer
RadioMedix raised $40 Million in a Series A round, dated October 7, 2022. RadioMedix is based in Houston, Texas, United States.
- How much did RadioMedix raise?
- RadioMedix raised $40 Million in a Series A round on October 7, 2022.
- What does RadioMedix do?
- RadioMedix, Inc. is a biotechnology company, based in Houston, Texas, focused on innovative targeted radio-pharmaceuticals for diagnosis, monitoring and therapy of cancer.
- Where is RadioMedix based and how big is it?
- RadioMedix is based in Houston, Texas, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as RadioMedix that raised within 45 days of this round, from Fundz verified event records.
- Opna Bio raised $38M (Series A) on November 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Arialys Therapeutics raised $14M on November 18, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Cue Biopharma raised an undisclosed amount (Funding Round) on November 17, 2022.
- Cue Biopharma raised $30M on November 16, 2022.
Who to call at RadioMedix, and when
A new round usually means RadioMedix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RadioMedix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RadioMedix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RadioMedix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RadioMedix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansRadioMedix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.